The Ian Peter Rennert Lectureship in Pediatric Oncology
The Ian Peter Rennert Lectureship in Pediatric Oncology was created by Owen and Sandra Rennert in celebration of their son Ian’s life and to honor his memory. Ian was a beloved son and brother, and had a deep passion for learning and for the outdoors. Ian died from non-Hodgkins lymphoma during his freshman year at Harvard University.
The annual lectureship at the Georgetown Lombardi Comprehensive Cancer Center was established with the purpose of providing educational opportunities for Georgetown University faculty and students by world renowned experts in pediatric cancer research and treatment. Dr. Rennert is a former chair of the Department of Pediatrics at Georgetown University Medical Center.
This Year’s Lecture: “One and Done: Gene Therapy Offers a New Paradigm for Cancer Immunotherapy”
Featured Speaker:
Timothy Cripe, MD, PhD
Chief, Division of Pediatric Hematology/ Oncology/ Blood and Marrow Transplant and Gordon Teter Endowed Chair in Pediatric Cancer, Nationwide Children’s Hospital, Columbus, Ohio
Member, Translational Therapeutics Program, The OSUCCC – James
Location: New Research Building Auditorium
Speaker Bio:
Dr. Timothy Cripe is the Chief of the Division of Pediatric Hematology/Oncology/Blood and Marrow Transplant and the Gordon Teter Endowed Chair in Pediatric Cancer at Nationwide Children’s Hospital. He is also a principal investigator in the Center for Childhood Cancer Research at the Abigail Wexner Research Institute at Nationwide Children’s Hospital. He is a tenured Professor of Pediatrics at The Ohio State University Wexner College of Medicine and a member of the Translational Therapeutics Program and the Pelotonia Institute for Immuno-Oncology at the OSU Comprehensive Cancer Center. His research is focused on the laboratory-based development and early phase clinical testing of cellular, viral and gene therapies for pediatric cancers and has been supported by numerous extramural grants including multiple R-, U- and P-level NIH grants. He has published over 150 peer-reviewed manuscripts and delivered over 220 invited lectures. He is the PI of a T32 training grant in pediatric cancer. He is the former chair of the FDA’s Cellular, Tissue and Gene Therapy Advisory Committee. He serves as the Editor-in-Chief of the flagship cancer journal of the American Society of Cell and Gene Therapy, Molecular Therapy Oncology. He is the founder of the educational podcast series “This Week in Pediatric Oncology” and has published 112 episodes. He is co-founder and board member of Vironexis Biotherapeutics, Inc., a clinical stage cancer gene therapy company.